	UK recommendations for Ki-67 immunohistochemical staining and interpretation in breast cancer. Histopathology Shaaban AM, Dodson A, Rakha E, Ellis I, Rea D, Quinn C, Provenzano E, Pinder S, UK National Coordinating Committee for Breast Pathology (NCCBP), Association of Breast Pathology (ABP) and the UK National External Quality Assessment Scheme for Immunohistochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). PMID: 42470171 [PubMed - as supplied by publisher]
	Histological grading of invasive breast carcinoma in the digital era: a practical framework for whole slide imaging. Histopathology Rakha EA. PMID: 42470156 [PubMed - as supplied by publisher]
	Predicting breast cancer pathological complete response with clinical and imaging data. Future Oncol Tao X, Li Y, Ye Y, Liang X, Qiu X, Zhao J. PMID: 42470141 [PubMed - as supplied by publisher]
	Causal assessment of 187 dietary habits with ovarian cancer from multiple sources via Mendelian randomization and meta-analysis. Medicine (Baltimore) Yu C, Ruoxi Z, Xu J, Ye Z. PMID: 42469968 [PubMed - indexed for MEDLINE]
	Nurse-led intervention for improving quality of life of breast cancer patients: systematic review and meta-analysis. BMC Nurs Fu J, Zhu X, Feng J. PMID: 42469823 [PubMed]
	Notch receptors in breast cancer: context-dependent roles and therapeutic targeting. Cell Commun Signal Wang M, Mi Y, Ye Q. PMID: 42469819 [PubMed - as supplied by publisher]
	Understanding cachexia and muscle dysfunction in the context of metastatic breast cancer. Cancer Metastasis Rev Saunders AAE, Anderson RL, Gregorevic P. PMID: 42469541 [PubMed - indexed for MEDLINE]
	Risk-based breast cancer screening. Br J Cancer Jørgensen KJ, Brodersen JB. PMID: 42469440 [PubMed - as supplied by publisher]
	Breast cancer detection and classification via a robust deep learning approach. Sci Rep Makram M, Aziz AS, Saeid MM, Mohamed MT. PMID: 42469341 [PubMed - indexed for MEDLINE]
	A Machine-Learning Model Using Pre-treatment Multimodal Data to Predict Sentinel Lymph Node Status After Neoadjuvant Chemotherapy in Operable Early-stage Breast Cancer. Acad Radiol Jin M, Yang A, Liu Y, Peng Y, Tian J, Ou W, Jiang J, Duan Z, Shu J. PMID: 42469044 [PubMed - as supplied by publisher]
	Foundation Model-empowered Multimodal Prediction of Platinum Resistance in High-grade Serous Ovarian Cancer: A Multicenter Retrospective Study. Acad Radiol Bi Q, Qu L, Liu Y, Wang Q, Meng Q, Yang J, Wu Y, Ai C, Miao K, Wu L. PMID: 42469040 [PubMed - as supplied by publisher]
	Non-Pharmacological Interventions for Postoperative Pain in Breast Cancer Patients: A Network Meta-analysis. Pain Manag Nurs Wang Y, Song J, Zhang H, Maniago J, Li Y, Xia Z, Zhang D, Sun W, Jiang H. PMID: 42469038 [PubMed - as supplied by publisher]
	Current Status and Prospects of Chemotherapy-Free Strategies in Ovarian Cancer. Crit Rev Oncol Hematol Jiang C, Li Z. PMID: 42468792 [PubMed - as supplied by publisher]
	The RAC1 tripartite hub: coupling metabolic plasticity and immune evasion to dictate breast cancer cell fate. Biochem Pharmacol Lin HY, Chen YH, Chu PY. PMID: 42468635 [PubMed - as supplied by publisher]
	Dosimetry and toxicity outcomes of knowledge-based volumetric modulated arc therapy for breast cancer: A retrospective cohort analysis. Radiother Oncol Chan J, Knight A, Baker L, Metz G, Morgia M, Lamoury G, Bromley R, Griffiths B, Carroll S. PMID: 42468606 [PubMed - as supplied by publisher]
	Axillary Management After Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer. Clin Breast Cancer Gu Z, Zhang Y, Ye Y, Qian W. PMID: 42468453 [PubMed - as supplied by publisher]
	Striving for completeness: Women's long-term experiences of living with a reconstructed breast after breast cancer - an interview study. Eur J Oncol Nurs Ahlstedt Karlsson S, Andrade C, Myrin-Westesson L, Larsson C, Uusimaki A, Svensson K, Paganini A. PMID: 42468414 [PubMed - as supplied by publisher]
	A practical approach to breast cancer risk assessment and management of women at elevated risk. Maturitas Etkin-Kramer E, Pederson HJ, Larkin LC. PMID: 42468287 [PubMed - as supplied by publisher]
	Ovarian Cancer Diagnosis and Chemoresistance Prediction Model Based on cfRNA Molecular Signature. Adv Sci (Weinh) Guo Q, Zhang Y, Jin Y, Deng S, Chen Y, Feng Z, Wen H, Wang L, Li Y, Ou F, Shen Y, Li H, Zhou T, Ju X, Wu X. PMID: 42467997 [PubMed - as supplied by publisher]
	Metabolic signatures of triple-negative breast cancer. Mol Biol Rep Pusalkar G, Madamakki R, Chakraborty P, Parodi A, Lopus M. PMID: 42467335 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 332383

Page 1 of 16620



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy